Use of Gene Markers as a Novel Method to Predict Loss of Ovarian Function Due to Breast Cancer Treatment

John       Yeh

doi:10.2174/157340481602200313100543

[1] 
Shayan A, Refaei M, Jamshidi F. Investigating the effect of cognitive-behavioral stress management on occupational performance among women with breast cancer. Curr Women Health Rev  2020; 16(2): 152-9.
[2] 
Oktay K, Harvey BE, Partridge AH, et al. Fertility preservation in patients with cancer: ASCO Clinical Practice Guideline Update. J Clin Oncol  2018; 36: 1994-2001.
[3] 
Tucker EJ, Grover SR, Bachelot A, Touraine P, Sinclair AH. Premature ovarian insufficiency: New perspectives on genetic cause and phenotypic spectrum. Endocr Rev  2019; 37: 609-35.
[4] 
Franca MM, Mendonca BB. Genetics of primary ovarian insufficiency in the next-generation sequencing era. JES  2020; 4: 1-16.

Rights & Permissions Print Cite

Article Metrics

24

1

Journal Information

For Authors

For Editors

For Reviewers

Explore Articles

Open Access

Open Access Articles

For Visitors

DOI https://dx.doi.org/10.2174/157340481602200313100543	Print ISSN 1573-4048
Publisher Name Bentham Science Publisher	Online ISSN 1875-6581

Current Women`s Health Reviews

Use of Gene Markers as a Novel Method to Predict Loss of Ovarian Function Due to Breast Cancer Treatment

Related Articles